Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 956-966

  Winkler, James D ^a   Eris, Tamer ^a   Sung, Chiu Mei ^a   Chabot Fletcher, Marie ^a   Mayer, Ruth J ^a   Surette, Marc E ^b   Chilton, Floyd H ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O OCTADECYL 2 O METHYL SN GLYCERO 3 PHOSPHOCHOLINE; ANTINEOPLASTIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; COENZYME A INDEPENDENT TRANSACYLASE; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIAGNOSIS; DRUG MECHANISM; ENZYME BINDING; ENZYME KINETICS; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ACYLTRANSFERASES; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARACHIDONIC ACID; CELL DIVISION; COENZYME A; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; LIPID METABOLISM; NF-KAPPA B; PHOSPHOLIPID ETHERS; PHOSPHOLIPIDS;

EID: 0030426905     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. ANDREESEN, R.: Ether lipids in the therapy of cancer. Prog. Biochem. Pharmacol. 22: 118-131, 1988.
2. ANDREESEN, R., MODOLELL, M. AND MUNDER, P. G.: Selective sensitivity of chronic myelogenous leukemia cell populations to alkyl-lysophospholipids. Blood 54: 519-523, 1979.
3. ANDREESEN, R. AND MUNDER, P. G.: Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid. J. Natl. Cancer Inst. 70: 623-627, 1983.
4. BERDEL, W. E., BAUSERT, W. R. E., FINK, U., RASTETLER, J. AND MUNDER, P. G.: Antitumor action of alkyl-lysophospholipids. Anticancer Res. 1: 345-352, 1981.
5. BERDEL, W. E., SCHLEHE, M., FINK, U., EMMERICH, B., MAUBACH, P. A., EMSLANDER, H. P., DAUM, S. AND RASTETTER, J.: Early tumor and leukemia response to alkyl-lysophospholipids in a Phase 1 study. Cancer 50: 2011-2015, 1982.
6. BERCAMASCHI, G., ROSTI, V., DANOVA, M., LUCOTTI, C. AND CAZZOLA, M.: Apoptosis: Biological and clinical aspects. Haematologica 79: 86-93, 1994.
7. BERGER, M. R. AND SCHMAHL, D.: Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids. Lipids 22: 935-942, 1987.
8. BLIGH, E. G. AND DYER, W. J.: A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917, 1959.
9. BOGGS, K. P., ROCK, C. O. AND JACKOWSKI, S.: Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. J. Biol. Chem. 270: 11612-11618, 1995a.
10. BOGGS, K. P., ROCK, C. O. AND JACKOWSKI, S.: Lysophosphatidylcholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine inhibit the CDP-choline pathway of phosphatidylcholine synthesis at the CTP:phosphocholine cytidylyltransferase step. J. Biol. Chem. 270: 7757-7764, 1995b.
11. BRACHWITZ, H., LANGEN, P., ARNDT, D. AND FICHTNER, I.: Cytostatic activity of synthetic O-alkylglycerolipids. Lipids 22: 897-903, 1987.
12. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
13. BUTCHER, R. D., WOJCIK, S. J., LINTS, T., WILSON, T., SCHOFIELD, P. C. AND RALPH, R.: Arachidonic acid, a growth signal in murine P815 mastocytoma cells. Cancer Res. 53: 3405-3410, 1993.
14. CARTER, G. W., YOUNG, P. R., ALBERT, D. H., BOUSKA, J., DYER, R., BELL, R. L., SUMMERS, J. B. AND BROOKS, D. W.: 5-Lipoxygenase inhibitory activity of zileuton. J. Pharmacol. Exp. Ther. 266: 929-937, 1991.
15. CHABOT, M. C., GREENE, D. G., BROCKSCHMIDT, J. K., CAPIZZI, R. L. AND WYKLE, R. L.: Ether-linked phosphoglyceride content of human leukemia cells. Cancer Res. 50: 7174-7178, 1990.
16. CHABOT, M. C., WYKLE, R. L., MODEST, E. J. AND DANIEL, L. W.: Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Cancer Res. 49: 4441-4445, 1989.
17. CHAPMAN, R. S., CHRESTA, C. M., HERBERG, A. A., BEERE, H. M., HEEH, S., WHETTON, A. D., HICKMAN, J. A. AND DIVE, C.: Further characterization of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukemic cells. Cytometry 20: 245-256, 1995.
18. CHATURVEDI, M. M., HIGUCHI, M. AND AGGARWAL, B. B.: Effect of tumor necrosis factors, interferons, interleukins, and growth factors on the activation of NF-kappaB: Evidence for lack of correlation with cell proliferation. Lymphokine Cytokine Res. 13: 309-313, 1994.
19. CHILTON, F. H., FONTEH, A. N., SUNG, C.-M., HICKEY, D. M. B., TORPHY, T. J., MAYER, R. J., MARSHALL, L. A., HERAVI, J. D. AND WINKLER, J. D.: Inhibitors of CoA-independent transacylase block the movement of arachidonate into 1-ether-linked phospholipids in human neutrophils. Biochemistry 34: 5403-5410, 1995.
20. CHILTON, F. H., FONTEH, A. N., SURETTE, M. E., TRIGGIANI, M. AND WINKLER, J. D.: Control of arachidonate levels within inflammatory cells. Biochim. Biophys. Acta 1299: 1-15, 1996.
21. CHILTON, F. H., O'FLAHERTY, J. T., ELLIS, J. M., SWENDSEN, C. L. AND WYKLE, R. L.: Selective acylation of lyso platelet-activating factor by arachidonate in human neutrophils. J. Biol. Chem. 258: 7268-7271, 1983.
22. CLELAND, W. W.: Statistical analysis of enzyme kinetic data. Methods Enzymol. 63: 103-138, 1979.
23. DANIEL, L. W., ETKIN, L., MORRISON, B. T., PARKER, J., MORRIS-NATSCHKE, S. AND PIANTADOSI, C.: Ether lipids inhibit the effects of phorbol dieter tumor promoters. Lipids 22: 851-855, 1987.
24. DENIZOT, Y., NAJID, A. AND RIGAUD, M.: Effects of eicosanoid metabolism inhibitors on growth of a human gastric tumor cell line. Cancer Lett. 73: 65-71, 1993.
25. DIOMEDE, L., PIOVANI, B., RE, F., PRINCIPE, P., COLOTTA, F., MODEST, E. J. AND SALMONA, M.: The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells. Int. J. Cancer 57: 645-649, 1994.
26. FUJIWARA, K., DANIEL, L. W., MODEST, E. J. AND WALLEN, C. A.: Relationship of cell survival, drug dose, and drug uptake after 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine treatment. Cancer Chemother. Pharmacol. 34: 472-476, 1994.
27. GORCZYCZ, W., GONG, J. AND DARZYNKIEWICZ, Z.: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53: 1945-1951, 1993.
28. HALDAR, S., JENA, N., DUBOIS, G. C., TAKAYAMA, S., REED, J. C., FU, S. S. AND CROCE, C. M.: Purification and characterization of the bcl-2 protein. Arch. Biochem. Biophys. 315: 483-488, 1994.
29. HERRMANN, D. B. J.: Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues. J. Natl. Cancer Inst. 75: 423-430, 1985.
30. HERRMANN, D. B. J. AND NEUMANN, H. A.: Cytotoxic ether phospholipids. Differential affinities to lysophosphocholine acyltransferase in sensitive and resistant cells. J. Biol. Chem. 17: 7742-7747, 1986.
31. HILGARD, P., STEKAR, J., VOEGELI, R., ENGEL, J., SCHUMACHER, W., EIBL, H., UNGER, C. AND BERGER, M. R.: Characterization of the antitumor activity of hexadecylphosphocholine. Eur. J. Cancer Clin. Oncol. 24: 1457-1461, 1988.
32. HOFFMAN, D. R., HAJDU, J. AND SNYDER, F.: Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils and skin fibroblasts. Blood 63: 545-552, 1984.
33. HOFFMAN, D. R., THOMAS, V. L. AND SNYDER, F.: Inhibition of cellular transport systems by alkyl phospholipid analogs in HL-60 human leukemia cells. Biochim. Biophys. Acta Lipids Metab. 1127: 74-80, 1992.
34. KERR, J. F. R., WINTERFORD, C. M. AND HARMON, B. V.: Apoptosis: Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
35. KRAMER, R. M. AND DEYKIN, D.: Arachidonoyl transacylase in human platelets. Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine. J. Biol. Chem. 258: 13806-13811, 1983.
36. LANGEN, P., MAURER, H. R., BRACHWITZ, H., ECKERT, K., VEIT, A. AND VOLLGRAF, C.: Cytostatic effects of various alkyl phospholipid analogues on different cell in vitro.. Anticancer Res. 12: 2109-2112, 1992.
37. LEE, P.-P. H. AND IP, M. M.: Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase. Prostaglandins Leukotrienes Essent. Fatty Acids 45: 21-31, 1992.
38. LU, X. AND ARTHUR, G.: Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines. Cancer Res. 52: 2806-2812, 1992a.
39. 3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids. Cancer Res. 52: 2813-2817, 1992b.
40. LU, X., ZHOU, X., KARDASH, D. AND ARTHUR, G.: Metabolism of alkyl lysophospholipid in epithelial cancer cell lines and inhibition of cell growth.. Biochem. Cell. Biol. 71: 122-126, 1993.
41. MACHLEIDT, T., WIEGMANN, K., HENKEL, T., SCHUTZE, S., BAEUERLE, P. AND KRONKE, M.: Sphingomyelinase activates proteolytic IkB-a degradation in a cell-free system. J. Biol. Chem. 269: 13760-13765, 1994.
42. MAJNO, G. AND JORIS, L: Apoptosis, oncosis, and necrosis: An overview of cell death. Am. J. Pathol. 146: 3-15, 1995.
43. 2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxic shock. J. Pharmacol. Exp. Ther. 274: 1254-1262, 1995.
44. MODOLELL, M., ANDREESEN, R., PAHLKE, W., BRUGGER, U. AND MUNDER, P. G.: Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. Cancer Res. 39: 4681-4686, 1979.
45. 3. Biochem. Biophys. Res. Commun. 192: 603-609, 1993.
46. MORRIS-NATSCHKE, S., SURLES, J. R., DANIEL, L. W., BERENS, M. E., MODEST, E. J. AND PIANTADOSI, C.: Synthesis of sulfur analogues of alkyl lysophospholipid and neoplastic cell growth inhibitory properties. J. Med. Chem. 29: 2114-2117, 1986.
47. NAJID, A., SIMON, A., DELAGE, C., CHULIA, A. J. AND RIGAUD, M.: A calluna vulgaris extract 5-lipoxygenase inhibitor shows potent antiproliferative effects on human meukemia HL-60 cells. Eicosanoids 5: 45-51, 1992.
48. 2 in plasma samples from patients with benign and malignant tumors of the breast. Prostaglandins 29: 513-528, 1985.
49. POWIS, G. AND PHIL, D.: Inhibitors of phosphatidylinositol signalling as anti-proliferative agents. Cancer Metastasis Rev. 13: 91-103, 1994.
50. RITKE, M. K., RUSNAK, J. M., LAZO, J. S., ALLAN, W. P., DIVE, C., HEER, S. AND YALOWICH, J. C.: Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol. Pharmacol. 46: 605-611, 1994.
51. 3 and hexadecylphosphocholine against mammary tumors in BD-VI rats. Lipids 22: 927-929, 1987.
52. SHEN, T. Y.: Indomethacin, sulindac and their analogs. In Anti-inflammatory and anti-rheumatic drugs, ed. by K. D. Rainsford and M. R. C. Path, pp. 149-159, CRC Press, Inc., Boca Raton, 1985.
53. SINGH, S. AND AGGARWAL, B. B.: Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kB. J. Biol. Chem. 270: 10631-10639, 1995.
54. SNYDER, F. AND WOOD, R.: The occurrence and metabolism of alkyl and alk-1-enyl ethers of glycerol in transplantable rat and mouse tumors. Cancer Res. 28: 972-978, 1968.
55. SNYDER, F., LEE, T. AND UEMURA, Y.: Involvement of a CoA-independent transacylase and unique transacetylase in the metabolism of PAF and related acetylated lipids. J. Lipid Mediat. 10: 25-31, 1994.
56. SNYDER, F. AND WOOD, R.: Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues. Cancer Res. 29: 251-257, 1969.
57. SQUIER, M. K. T., SEHNERT, A. J. AND COHEN, J. J.: Apoptosis in leukocytes. J. Leukocyte Biol. 57: 2-10, 1995.
58. 2. Biochemistry 32: 5935-5940, 1993.
59. SUGIURA, T., MASUZAWA, Y., NAKAGAWA, Y. AND WAKU, K.: Transacylation of lyso platelet-activating factor and other lysophospholipids by macrophage microsomes. Distinct donor and acceptor selectivities. J. Biol. Chem. 262: 1199-1205, 1987.
60. TIDWELL, T., GUZMAN, G. AND VOGLER, W. R.: The effects of alkyl-lysophospho-lipids on leukemic cell lines. Differential action on two human leukemic cell lines, HL-60 and K562. Blood 57: 794-797, 1981.
61. VERDONCK, L. F., WITTEVEEN, E. O., VAN HEUGTEN, H. G., ROZEMULLER, E. AND RIJKSEN, G.: Selective killing of malignant cells from leukemic patients by alkyl-lysopholipid. Cancer Res. 50: 4020-4025, 1990.
62. 2a in benign and malignant breast tumors. Br. J. Cancer 51: 827-836, 1985.
63. WILCOX, R. W., WYKLE, R. L., SCHMITT, J. D. AND DANIEL, L. W.: The degradation of platelet-activating factor and related lipids; susceptibility to phospholipases C and D. Lipids 22: 800-807, 1987.
64. WINKLER, J. D. AND CHILTON, F. H.: The role of CoA-independent transacylases in the production of platelet-activating factor and the metabolism of arachidonate. Drug News Perspect. 6: 133-138, 1993.
65. WINKLER, J. D. AND CHILTON, F. H.: Pharmacology of CoA-independent transacylase. In Inflammation: Mediators and Pathways, ed. by R. Ruffolo and J. Hollinger, pp. 147-171, CRC Press, Inc., Boca Raton, 1995.
66. WINKLER, J. D., FONTEH, A. N., SUNG, C.-M., HERAVI, J. D., NIXON, A. B., CHABOT-FLETCHER, M., GRISWOLD, D., MARSHALL, L. A. AND CHILTON, F. H.: Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators. J. Pharmacol. Exp. Ther. 274:1338-1347, 1995.
67. WINKLER, J. D., SUNG, C.-M., BENNETT, C. F. AND CHILTON, F. H.: Characterization of CoA-independent transacylase activity in U937 cells. Biochim. Biophys. Acta Lipids Metab. 1081: 339-346, 1991.
68. WORKMAN, P., DONALDSON, J. AND LOHMEYER, M.: Platelet-activating factor antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumor alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukemia cells. Biochem. Pharmacol. 41: 319-322, 1991.
69. ZHENG, B., OISHI, K., SHOJI, M., EIBL, H., BERDEL, W. E., HAJDU, J., VOGLER, W. R. AND KUO, J. F.: Inhibition of protein kinase C (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues. Cancer Res. 50: 3025-3031, 1990.